article thumbnail

Community Pharmacies and Anabolic-Androgenic Steroid Consumers

Common Sense for Drug Policy Blog

Community Pharmacies and Anabolic-Androgenic Steroid Consumers "With the growing availability of AAS [Anabolic-Androgenic Steroids] through online platforms [ 71 , 72 ] the traditional reliance on social networks and healthcare providers for access to injecting equipment and safer use information has diminished [ 73 – 76 ].

article thumbnail

British consumers have increasingly turned to community pharmacies during COVID-19

The Pharma Data

British consumers have increasingly turned to community pharmacies during the coronavirus pandemic, according to a new study. Research conducted by Ipsos Mori and commissioned by Johnson & Johnson Consumer Health EMEA surveyed between 6,000 people between 16 and 75. This rose to 68% in the 45-54 age bracket.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

World Suicide Prevention Day 2023: the Lifeguard Pharmacy study

On Medicine

The Lifeguard Pharmacy study tests whether a community pharmacy response service would offer a discreet and accessible help-seeking avenue for people experiencing suicidal ideation and/or domestic abuse. Monthly visits to the pharmacies by the research team monitored intervention fidelity. How did we do it?

Pharmacy 105
article thumbnail

UK consumers seeking advice from pharmacists during pandemic, research finds

The Pharma Data

New research from Ipsos MORI has found that UK consumers have turned to community pharmacists during COVID-19 for healthcare advice and more. In addition to an increase in online engagement, 29% of UK consumers visited a pharmacy to buy healthcare products during the lockdown period. Source link.

article thumbnail

Buprenorphine now replaces methadone as the most common medicine for opioid dependence’: 10-year trends in opioid agonist treatment medicines in Australia

National Drug & Alcohol Research Centre Blog

The use of opioid agonist treatment increased in non-community pharmacy settings from early 2020. Increases were seen for buprenorphine. However, the number of client-months on methadone over the study period remained relatively stable. This increase was particularly evident in drug and alcohol outpatient clinics and prisons.

Treatment 133
article thumbnail

DrugBank adds ASHP data to knowledgebase, improving user experience and data reliability

DrugBank

Together with DrugBank’s complementary products, this integration is expected to improve consumer safety, provide users with a stronger understanding of trends across categories and the research landscape, and enhance analytic capabilities.

article thumbnail

Childhood trauma associated with increased risk of opioid use disorder (OUD) among people prescribed opioids for chronic non-cancer pain.

National Drug & Alcohol Research Centre Blog

A new study by National Drug and Alcohol Research Centre (NDARC) researchers, led by PhD candidate Thomas Santo Jr, describes childhood trauma exposure among a sample of people prescribed opioids for CNCP. This type of e xposure is associated with neurobiological and psychosocial harm that may continue through adulthood.